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Between 1 May 2005 and 31 May 2011 researchers from the Institute of Psychiatry, Psychology and Neuroscience at King's College London studied 410 patients who had experienced a first episode of psychosis and collected data on their cannabis use. These data were compared with data collected from 370 people from the same area of south London who had never experienced a psychotic episode.
Patients who had experienced psychosis were no more likely than controls to report having ever used cannabis (67% versus 63% of participants) but were more likely to use cannabis every day (123 of 410 (30%) versus 41 of 370 (11%)) and to mostly use skunk-like cannabis (218 of 410 (53%) versus 70 of 370 (19%)).
The likelihood of having experienced an episode of psychotic disorder among users of skunk-like cannabis was three times that among people who never used cannabis (adjusted odds ratio 2.92 (95% confidence interval 1.52 to 3.45; P=0.001)). In daily users that risk increased dramatically: the risk of psychosis was five times as high in people who smoked skunk-like cannabis as in those who never used cannabis (adjusted odds ratio 5·4 (2·81 to 11·31); P=0·002).
When the researchers extrapolated the results across the population of south London from which the participants were drawn, they calculated use of high potency cannabis to be associated with 24% (95% confidence interval 17% to 31%) of new cases of psychosis.
Marta Di Forti, the study's lead author, said, "The results show that psychosis risk in cannabis users depends on both the frequency of use and cannabis potency. The use of hash was not associated with increased risk of psychosis."
She said that just as with smoking tobacco and drinking alcohol there needed to be a clear public health message on cannabis that highlighted the dangers of high potency and more frequent use. "'When a GP or psychiatrist asks if a patient uses cannabis it's not helpful-it's like asking whether someone drinks. As with alcohol, the relevant questions are how often and what type of cannabis. This gives more information about whether the user is at risk of mental health problems; awareness needs to increase for this to happen." Robin Murray, professor of psychiatric research at the Institute of Psychiatry, Psychology and Neuroscience, said, "It is now well known that use of cannabis increases the risk of psychosis. However, sceptics still claim that this is not an important cause of schizophrenia-like psychosis.
"This paper suggests that we could prevent almost one quarter of cases of psychosis if no one smoked high potency cannabis. This could save young patients a lot of suffering and the NHS a lot of money." 
